601 related articles for article (PubMed ID: 28224211)
1. Mechanisms overseeing myeloid-derived suppressor cell production in neoplastic disease.
Netherby CS; Abrams SI
Cancer Immunol Immunother; 2017 Aug; 66(8):989-996. PubMed ID: 28224211
[TBL] [Abstract][Full Text] [Related]
2. The Granulocyte Progenitor Stage Is a Key Target of IRF8-Mediated Regulation of Myeloid-Derived Suppressor Cell Production.
Netherby CS; Messmer MN; Burkard-Mandel L; Colligan S; Miller A; Cortes Gomez E; Wang J; Nemeth MJ; Abrams SI
J Immunol; 2017 May; 198(10):4129-4139. PubMed ID: 28356386
[TBL] [Abstract][Full Text] [Related]
3. Relevance of Interferon Regulatory Factor-8 Expression in Myeloid-Tumor Interactions.
Abrams SI; Netherby CS; Twum DY; Messmer MN
J Interferon Cytokine Res; 2016 Jul; 36(7):442-53. PubMed ID: 27379866
[TBL] [Abstract][Full Text] [Related]
4. Multimodal Intralesional Therapy for Reshaping the Myeloid Compartment of Tumors Resistant to Anti-PD-L1 Therapy via IRF8 Expression.
Patel A; Oba T; Kajihara R; Yokoi T; Abrams SI; Ito F
J Immunol; 2021 Sep; 207(5):1298-1309. PubMed ID: 34362833
[TBL] [Abstract][Full Text] [Related]
5. Myeloid-derived suppressor cell development is regulated by a STAT/IRF-8 axis.
Waight JD; Netherby C; Hensen ML; Miller A; Hu Q; Liu S; Bogner PN; Farren MR; Lee KP; Liu K; Abrams SI
J Clin Invest; 2013 Oct; 123(10):4464-78. PubMed ID: 24091328
[TBL] [Abstract][Full Text] [Related]
6. IFN regulatory factor 8 represses GM-CSF expression in T cells to affect myeloid cell lineage differentiation.
Paschall AV; Zhang R; Qi CF; Bardhan K; Peng L; Lu G; Yang J; Merad M; McGaha T; Zhou G; Mellor A; Abrams SI; Morse HC; Ozato K; Xiong H; Liu K
J Immunol; 2015 Mar; 194(5):2369-79. PubMed ID: 25646302
[TBL] [Abstract][Full Text] [Related]
7. Interferon regulatory factor 4 (IRF4) controls myeloid-derived suppressor cell (MDSC) differentiation and function.
Nam S; Kang K; Cha JS; Kim JW; Lee HG; Kim Y; Yang Y; Lee MS; Lim JS
J Leukoc Biol; 2016 Dec; 100(6):1273-1284. PubMed ID: 27601624
[TBL] [Abstract][Full Text] [Related]
8. Myeloid-Derived Suppressor Cells in the Tumor Microenvironment: Current Knowledge and Future Perspectives.
Ibáñez-Vea M; Zuazo M; Gato M; Arasanz H; Fernández-Hinojal G; Escors D; Kochan G
Arch Immunol Ther Exp (Warsz); 2018 Apr; 66(2):113-123. PubMed ID: 29032490
[TBL] [Abstract][Full Text] [Related]
9. Mitigating the prevalence and function of myeloid-derived suppressor cells by redirecting myeloid differentiation using a novel immune modulator.
Oliver L; Alvarez R; Diaz R; Valdés A; Colligan SH; Nemeth MJ; Twum DYF; Fernández A; Fernández-Medina O; Carlson LM; Yu H; Eng KH; Hensen ML; Rábade-Chediak ML; Fernández LE; Lee KP; Perez L; Muhitch JB; Mesa C; Abrams SI
J Immunother Cancer; 2022 Sep; 10(9):. PubMed ID: 36150744
[TBL] [Abstract][Full Text] [Related]
10. IRF7 regulates the development of granulocytic myeloid-derived suppressor cells through S100A9 transrepression in cancer.
Yang Q; Li X; Chen H; Cao Y; Xiao Q; He Y; Wei J; Zhou J
Oncogene; 2017 May; 36(21):2969-2980. PubMed ID: 28092673
[TBL] [Abstract][Full Text] [Related]
11. IRF8: Mechanism of Action and Health Implications.
Moorman HR; Reategui Y; Poschel DB; Liu K
Cells; 2022 Aug; 11(17):. PubMed ID: 36078039
[TBL] [Abstract][Full Text] [Related]
12. Deregulation of apoptotic factors Bcl-xL and Bax confers apoptotic resistance to myeloid-derived suppressor cells and contributes to their persistence in cancer.
Hu X; Bardhan K; Paschall AV; Yang D; Waller JL; Park MA; Nayak-Kapoor A; Samuel TA; Abrams SI; Liu K
J Biol Chem; 2013 Jun; 288(26):19103-15. PubMed ID: 23677993
[TBL] [Abstract][Full Text] [Related]
13. Suppression of T cells by myeloid-derived suppressor cells in cancer.
Chen J; Ye Y; Liu P; Yu W; Wei F; Li H; Yu J
Hum Immunol; 2017 Feb; 78(2):113-119. PubMed ID: 27939507
[TBL] [Abstract][Full Text] [Related]
14. Granulocytic Myeloid-Derived Suppressor Cells as Negative Regulators of Anticancer Immunity.
Kramer ED; Abrams SI
Front Immunol; 2020; 11():1963. PubMed ID: 32983128
[TBL] [Abstract][Full Text] [Related]
15. Immunotherapy Targeting Myeloid-Derived Suppressor Cells (MDSCs) in Tumor Microenvironment.
Gao X; Sui H; Zhao S; Gao X; Su Y; Qu P
Front Immunol; 2020; 11():585214. PubMed ID: 33613512
[TBL] [Abstract][Full Text] [Related]
16. Myeloid-Derived Suppressor Cells Produce IL-10 to Elicit DNMT3b-Dependent IRF8 Silencing to Promote Colitis-Associated Colon Tumorigenesis.
Ibrahim ML; Klement JD; Lu C; Redd PS; Xiao W; Yang D; Browning DD; Savage NM; Buckhaults PJ; Morse HC; Liu K
Cell Rep; 2018 Dec; 25(11):3036-3046.e6. PubMed ID: 30540937
[TBL] [Abstract][Full Text] [Related]
17. Glycolysis regulates the expansion of myeloid-derived suppressor cells in tumor-bearing hosts through prevention of ROS-mediated apoptosis.
Jian SL; Chen WW; Su YC; Su YW; Chuang TH; Hsu SC; Huang LR
Cell Death Dis; 2017 May; 8(5):e2779. PubMed ID: 28492541
[TBL] [Abstract][Full Text] [Related]
18. SETD1B Activates iNOS Expression in Myeloid-Derived Suppressor Cells.
Redd PS; Ibrahim ML; Klement JD; Sharman SK; Paschall AV; Yang D; Nayak-Kapoor A; Liu K
Cancer Res; 2017 Jun; 77(11):2834-2843. PubMed ID: 28381543
[TBL] [Abstract][Full Text] [Related]
19. IRF-8 regulates expansion of myeloid-derived suppressor cells and Foxp3+ regulatory T cells and modulates Th2 immune responses to gastrointestinal nematode infection.
Valanparambil RM; Tam M; Gros PP; Auger JP; Segura M; Gros P; Jardim A; Geary TG; Ozato K; Stevenson MM
PLoS Pathog; 2017 Oct; 13(10):e1006647. PubMed ID: 28968468
[TBL] [Abstract][Full Text] [Related]
20. Nanoparticle Systems Modulating Myeloid-Derived Suppressor Cells for Cancer Immunotherapy.
Wilkerson A; Kim J; Huang AY; Zhang M
Curr Top Med Chem; 2017; 17(16):1843-1857. PubMed ID: 27875974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
